{
  "schema_version": "0.1.0",
  "case_id": "HR-ML039",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML039",
    "display_name": "Jacqueline du Pré",
    "aliases": [
      "Jacqueline Mary du Pré",
      "Jacqueline du Pre"
    ],
    "name_parts": {
      "given": [
        "Jacqueline",
        "Mary"
      ],
      "family": "du Pré",
      "family_first": false
    },
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "English",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1945-01-26",
          "display": "26 January 1945",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1945",
              "display": "1945",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with Wikipedia, Women in World History and the 2018 review."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1987-10-19",
          "display": "19 October 1987",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1987",
              "display": "1987",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the sources."
          },
          {
            "date": {
              "iso": "1987-10-20",
              "display": "20 October 1987",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0004"
            ],
            "resolution_status": "conflicting",
            "note": "Women in World History gives 20 October, the date of the New York Times obituary; Wikipedia and the 2018 review give 19 October."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML039-SYN",
      "ssn": "000-39-7062",
      "date_of_birth": "1998-01-26",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Imogen Thackeray-Osei, MD",
      "fictional_consultant": {
        "name": "Rafael Lindgren-Achebe, MD",
        "specialty": "Neurology (multiple sclerosis)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1945-01-26",
        "display": "26 January 1945",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Oxford, England.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1961-03",
        "display": "March 1961",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Formal debut at Wigmore Hall, London, at 16, after the Suggia Award and the Queen's Prize.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1965",
        "display": "1965",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Records the Elgar Cello Concerto.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1967-06",
        "display": "June 1967",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Converts to Judaism and marries.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1971",
        "display": "1971",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Loses sensitivity in her fingers; returns to England exhausted and takes a sabbatical; the numbness worsens on her return to the stage in 1972.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1973-02",
        "display": "February 1973",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Last public concerts, in London and New York.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1973-10",
        "display": "October 1973",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Diagnosed with multiple sclerosis in London at 28; her performing career ends.",
      "claim_ids": [
        "CLM-0008",
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1976",
        "display": "1976",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Appointed OBE; teaches and gives master classes, and raises funds for MS research.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1987-10-19",
        "display": "19 October 1987",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies of multiple sclerosis in London at 42.",
      "claim_ids": [
        "CLM-0012"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Jacqueline Mary du Pré was born in Oxford, England, on 26 January 1945. Her mother was a pianist who had studied at the Royal Academy of Music, and her father an accountant.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Jacqueline Mary du Pré; born in Oxford, England, 26 January 1945; mother a concert pianist who had studied at the Royal Academy of Music; father an accountant"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "born in Oxford on 26 January 1945; her parents were both British musicians"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "born in Oxford, England, on January 26, 1945"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "context",
          "locator": "roster birth date"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She began the cello as a small child, studied with William Pleeth at the Guildhall School of Music from the mid-1950s, won the Guilhermina Suggia Award at 11 in 1956 and the Queen's Prize at 15, attended a Pablo Casals masterclass in Zermatt in 1960, and made her formal debut at Wigmore Hall in London in March 1961, at 16.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a professional cellist since her teens.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "studying at the Guildhall School of Music with William Pleeth; Guilhermina Suggia Award in 1956 at 11; Casals masterclass in Zermatt; formal debut at Wigmore Hall in March 1961 at 16"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "at 15 she won Guildhall's Gold Medal as well as the Queen's Prize; concert debut at Wigmore Hall at 16"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Gilhermina Suggia scholarship at 11; youngest person ever to be awarded the Queen's Prize"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1965, at 20, she recorded Elgar's Cello Concerto with the London Symphony Orchestra under Sir John Barbirolli; she played chiefly on the Davidov Stradivarius of 1712.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her documented career anchors the modern plan built around hand function and performance.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "In 1965, at age 20, du Pré recorded the Elgar Concerto for EMI; the Davidov Stradivarius of 1712"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "recorded the Elgar concerto with the London Symphony Orchestra under Barbirolli in 1965"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "She converted to Judaism and married her husband, a pianist and conductor, in Jerusalem in June 1967.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; her husband is not named and is given no role in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "she converted to Judaism and they married at the Western Wall on 15 June 1967"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "In 1971 her playing declined as she began to lose sensitivity in her fingers and other parts of her body; she returned to England exhausted, took a sabbatical from 1971 to 1972 and performed only rarely. When she resumed in 1972 the numbness in her fingers worsened, with fatigue.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern presenting problem (numbness and clumsiness of the hands, fatigue).",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "In 1971, du Pré's playing declined as she began to lose sensitivity in her fingers and other parts of her body; sabbatical from 1971 to 1972"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "In 1971 she returned unexpectedly to England with profound exhaustion; in 1972 her finger numbness worsened, with fatigue"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "fatigue, a common early symptom of MS, and finger paresthesia"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "Two physicians writing about her illness note episodes of blurred vision in her teens, which they read as possibly an early sign of multiple sclerosis.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation; not used as part of the modern history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "During her teens, du Pré had episodes of blurred vision, often indicative of MS"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Her last public concerts were in February 1973, in London, where she played the Elgar Concerto, and in New York.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Dates the end of her performing; the modern index visit follows it.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Her last public concerts took place in New York in February 1973"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "In February 1973, the late Jacqueline du Pré performed the Elgar Cello Concerto in London; almost her last public performance"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "She was diagnosed with multiple sclerosis in London in October 1973, at 28, about four years after her first symptoms; the diagnosis ended her career as a performer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented diagnosis to which the modern diagnosis is linked.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "She was diagnosed with multiple sclerosis in October 1973"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "diagnosed with multiple sclerosis in October 1973 in London, four years after the onset of her symptoms"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She went on teaching and giving master classes, singing or whistling the musical lines and explaining the fingering when she could no longer play, and remained a teacher and mentor until her death. She was appointed an Officer of the Order of the British Empire in the 1976 New Year Honours.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her documented teaching anchors the modern plan built around her music.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "for a time she was able to teach master classes; she whistled the musical parts and explained the fingering to her students"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "remained active as a teacher and mentor until her death; OBE in the 1976 New Year Honours"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "described by students as a wonderful teacher; in 1976 she received the OBE"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "Corticosteroids were the treatment available to her; physicians writing later judge that her illness followed a relapsing-remitting course that became secondary progressive.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Retrospective; the published reviews note that no medical records are public.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "steroids shortened the duration of disability following an acute attack; seemingly meets the criteria for relapsing remitting MS with secondary progression"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "corticosteroids were the available treatment; no public medical records exist"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "After her diagnosis and retirement she raised funds for multiple sclerosis research; fellowships in her name later funded travel grants for early-career MS researchers.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Following her announced diagnosis and retirement, du Pré raised funds for MS research; the du Pré fellowships fund year-long travel grants for early-career MS researchers"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "She died of multiple sclerosis in London on 19 October 1987, at 42, and was buried in Golders Green Jewish Cemetery. One reference work gives 20 October.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented death from multiple sclerosis. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "died in London on 19 October 1987 at age 42; buried in Golders Green Jewish Cemetery"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died on 19 October 1987 at age 42"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "died on October 20, 1987, in London, of multiple sclerosis"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Tierradentro-García LO, Botero-Meneses JS, Talero-Gutiérrez C. The Sound of Jacqueline du Pré: Revisiting her Medical and Musical History. Mult Scler J Exp Transl Clin 2018;4(2):2055217318775756 (PMID 29780612)",
      "publisher": "SAGE (Multiple Sclerosis Journal - Experimental, Translational and Clinical)",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5952293/",
      "source_type": "scholarly",
      "published": "2018-05-10",
      "accessed": "2026-11-05",
      "rights_note": "Open-access peer-reviewed review; facts and short quotations used with citation. It gives the year of her last concert as 1972, which the other sources contradict, and is not used for that."
    },
    {
      "source_id": "SRC-0002",
      "title": "Dacy LC, Rodriguez M. The interrupted concerto: Jacqueline du Pré and MS (Hektoen International, Fall 2014)",
      "publisher": "Hektoen International: A Journal of Medical Humanities",
      "url": "https://hekint.org/?p=2751",
      "source_type": "other",
      "published": "2014",
      "accessed": "2026-11-05",
      "rights_note": "Medical humanities essay by two Mayo Clinic physicians; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Jacqueline du Pré",
      "publisher": "Wikipedia",
      "url": "https://en.wikipedia.org/wiki/Jacqueline_du_Pr%C3%A9",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Tertiary source used for her training, debut, recordings, the 1971 symptoms and sabbatical, the last concerts, the diagnosis date, the OBE and her death, and as a pointer to its sources. Its account of contested later claims about her family and death is not used."
    },
    {
      "source_id": "SRC-0004",
      "title": "du Pré, Jacqueline (1945-1987) (Women in World History: A Biographical Encyclopedia)",
      "publisher": "Encyclopedia.com (Gale)",
      "url": "https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/du-pre-jacqueline-1945-1987",
      "source_type": "other",
      "accessed": "2026-11-05",
      "rights_note": "Reference encyclopedia entry; used for her prizes, teaching after the diagnosis and the cause of death; it gives the death date as 20 October."
    },
    {
      "source_id": "SRC-0005",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-05",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-09",
    "index_age": 28,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize multiple sclerosis in a professional musician of 28 whose numbness and clumsiness of the fingers and fatigue could be put down to overwork or stress, as hers were for years, and care for it on the AAN 2018 disease-modifying therapy guideline, the ECTRIMS/EAN 2018 guideline and NICE NG220: urgent MRI of the brain and spine with gadolinium; diagnosis by the 2017 McDonald criteria (and their 2024 revision), with cerebrospinal fluid oligoclonal bands and exclusion of mimics (vitamin B12, thyroid, aquaporin-4 antibody for a myelitis; MOG antibody only when the picture suggests it); high-dose corticosteroids for a disabling relapse; early high-efficacy disease-modifying therapy, choosing among ocrelizumab, ofatumumab and natalizumab with JCV antibody status, infusion logistics and pregnancy plans; hepatitis B screening, immunoglobulins and vaccinations before B-cell therapy; vitamin D; infection and pseudo-relapse; fatigue; hand function with occupational therapy; and a plan built around her playing and teaching, set against the four years it took to name her illness in the 1970s, when no disease-modifying treatment existed.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-09",
        "purpose": "Three weeks of numbness and clumsiness in the fingers of both hands, with Lhermitte's sign and fatigue, in a professional cellist of 28: examination, blood tests, and urgent MRI of the brain and spine"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-23",
        "purpose": "Diagnosis of relapsing-remitting multiple sclerosis: neurology consultation, treatment of the relapse, choice of high-efficacy disease-modifying therapy, and vaccinations before B-cell therapy"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-27",
        "purpose": "Second half-dose of the first ocrelizumab course: recovery of hand function, infusion reactions, vaccination, practice and work"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-06-15",
        "purpose": "Same-day sick visit for cystitis with a pseudo-relapse"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-07-13",
        "purpose": "Three months on ocrelizumab: re-baseline MRI, B-cell depletion, fatigue, vitamin D and hand function"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-14",
        "purpose": "Periodic adult preventive visit on B-cell therapy"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-12",
        "purpose": "Six months: first 600 mg dose of ocrelizumab, no evidence of disease activity, immunoglobulins, vaccination response, pregnancy planning and her return to performing"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Numbness, tingling and loss of position sense in the fingers of both hands for three weeks, worse on the left, with clumsiness that makes her lose her place on the fingerboard, an electric feeling down the spine on bending the neck (Lhermitte's sign), and fatigue; a similar month of tingling in the fingers 18 months ago settled on its own. A lesion of the cervical spinal cord must be found: MRI of the brain and spine with contrast booked this week",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R20.2",
            "display": "Paresthesia of skin",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to her documented loss of sensation in her fingers and fatigue. Superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-23"
      },
      {
        "id": "PRB-002",
        "display": "Relapsing-remitting multiple sclerosis, active: a current relapse (partial cervical myelitis at C3 to C4 with sensory loss and clumsiness of the hands) after an earlier sensory episode; dissemination in space and time on MRI, with an enhancing cord lesion and an enhancing brain lesion; CSF-specific oligoclonal bands; aquaporin-4 antibody negative; meets the 2017 McDonald criteria and the 2024 revision; synthetic modern detail linked to her documented diagnosis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G35.A",
            "display": "Relapsing-remitting multiple sclerosis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic course, imaging and laboratory detail; linked to her documented diagnosis in October 1973.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-23"
      },
      {
        "id": "PRB-003",
        "display": "Vitamin D deficiency: 25-hydroxyvitamin D 16 ng/mL; replacement to correct the deficiency, not as a treatment for multiple sclerosis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E55.9",
            "display": "Vitamin D deficiency, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-23"
      },
      {
        "id": "PRB-005",
        "display": "Acute uncomplicated cystitis (Escherichia coli) seven weeks after the first ocrelizumab course, with a pseudo-relapse: two days of returning tingling in the fingers with a low fever and no new neurological deficit; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N30.00",
            "display": "Acute cystitis without hematuria",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic intercurrent infection; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-15",
        "abatement_date": "2026-07-13"
      }
    ],
    "medications": [
      {
        "id": "MED-005",
        "display": "Nitrofurantoin macrocrystals 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1648759",
            "display": "nitrofurantoin, macrocrystals 100 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One capsule twice daily for 5 days"
        },
        "start_date": "2026-06-15",
        "end_date": "2026-06-19",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic first-line treatment of uncomplicated cystitis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "MED-001",
        "display": "Methylprednisolone 1000 mg injection, 1 g intravenously over one hour once daily for 3 days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1743726",
            "display": "methylprednisolone 1000 MG Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1 g daily for 3 days"
        },
        "start_date": "2026-03-24",
        "end_date": "2026-03-26",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic high-dose corticosteroid for a relapse limiting hand function, after a negative urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Cholecalciferol (vitamin D3) 4000 unit (100 microgram) oral capsule, one capsule by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1092380",
            "display": "cholecalciferol 0.1 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One capsule daily"
        },
        "start_date": "2026-03-23",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic vitamin D replacement for deficiency.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Ocrelizumab 30 mg/mL injection: first dose as 300 mg intravenously on day 1 and day 15, then 600 mg intravenously every 6 months, with methylprednisolone 100 mg, an antihistamine and acetaminophen before each infusion",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1876380",
            "display": "10 ML ocrelizumab 30 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 600,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 26,
          "period_unit": "wk",
          "text": "300 mg on days 1 and 15, then 600 mg every 6 months"
        },
        "start_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic anti-CD20 high-efficacy disease-modifying therapy; the first 600 mg dose is split into two 300 mg infusions two weeks apart.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 13.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; no anemia to explain the fatigue. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 6.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; no anemia to explain the fatigue. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V1",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; no anemia to explain the fatigue. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 246,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic blood count at presentation; no anemia to explain the fatigue. No result from her life is known; synthetic value.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 0.72,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 117,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 86,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 16,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 19,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic chemistry at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 468,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic vitamin B12; normal, against B12 deficiency as a cause of a dorsal column syndrome.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.6,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic TSH; normal, against thyroid disease as a cause of the fatigue.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGR-V1",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
        "label": "Nine-hole peg test, right hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-03-09",
        "value": 26.0,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83157-8",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test at presentation: slow in both hands, worse on the left (her fingering hand). Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGL-V1",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
        "label": "Nine-hole peg test, left hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-03-09",
        "value": 33.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83156-0",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test at presentation: slow in both hands, worse on the left (her fingering hand). Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V2",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 16,
        "unit": "ng/mL",
        "reference_range": {
          "low": 20,
          "high": 100,
          "text": "Below 20 ng/mL deficient; 20 to 29 insufficient"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D; deficient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGG-V2",
        "display": "IgG [Mass/volume] in Serum or Plasma",
        "label": "IgG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 1080,
        "unit": "mg/dL",
        "reference_range": {
          "low": 700,
          "high": 1600
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2465-3",
            "display": "IgG [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline IgG before B-cell therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGM-V2",
        "display": "IgM [Mass/volume] in Serum or Plasma",
        "label": "IgM",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-23",
        "value": 124,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40,
          "high": 230
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2472-9",
            "display": "IgM [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic baseline IgM before B-cell therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-23",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day of the diagnosis; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V2",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-03-23",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 on the day of the diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGR-V2",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
        "label": "Nine-hole peg test, right hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-03-23",
        "value": 24.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83157-8",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test on the day of the diagnosis, before steroids. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGL-V2",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
        "label": "Nine-hole peg test, left hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-03-23",
        "value": 31.0,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83156-0",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test on the day of the diagnosis, before steroids. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 13.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the second half-dose of ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 7.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the second half-dose of ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V3",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 1.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the second half-dose of ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 252,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the second half-dose of ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 90,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the second half-dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the second half-dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the second half-dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-27",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGR-V3",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
        "label": "Nine-hole peg test, right hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-04-27",
        "value": 20.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83157-8",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test four weeks after steroids, with occupational therapy. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGL-V3",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
        "label": "Nine-hole peg test, left hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-04-27",
        "value": 23.0,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83156-0",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test four weeks after steroids, with occupational therapy. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V6",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-15",
        "value": 10.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic white cell count at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CRP-V6",
        "display": "C reactive protein [Mass/volume] in Serum or Plasma",
        "label": "C-reactive protein",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-15",
        "value": 14,
        "unit": "mg/L",
        "reference_range": {
          "high": 5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1988-5",
            "display": "C reactive protein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic C-reactive protein at the sick visit; raised with infection.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 13.5,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count three months after starting ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 6.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count three months after starting ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V4",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 1.5,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count three months after starting ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 240,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count three months after starting ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CD19-V4",
        "display": "CD19 cells [#/volume] in Blood",
        "label": "CD19 B cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 3,
        "unit": "/uL",
        "reference_range": {
          "low": 100,
          "high": 500
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "8116-6",
            "display": "CD19 cells [#/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic CD19 B-cell count; depleted, as expected on anti-CD20 therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGG-V4",
        "display": "IgG [Mass/volume] in Serum or Plasma",
        "label": "IgG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 990,
        "unit": "mg/dL",
        "reference_range": {
          "low": 700,
          "high": 1600
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2465-3",
            "display": "IgG [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic IgG on ocrelizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V4",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 34,
        "unit": "ng/mL",
        "reference_range": {
          "low": 20,
          "high": 100,
          "text": "Below 20 ng/mL deficient; 20 to 29 insufficient"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D after 16 weeks of cholecalciferol.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-13",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGR-V4",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
        "label": "Nine-hole peg test, right hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-07-13",
        "value": 19.0,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83157-8",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test three months after the relapse. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGL-V4",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
        "label": "Nine-hole peg test, left hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-07-13",
        "value": 20.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83156-0",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test three months after the relapse. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 13.7,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 6.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYM-V5",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 1.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 238,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic blood count before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 121,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic chemistry before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGG-V5",
        "display": "IgG [Mass/volume] in Serum or Plasma",
        "label": "IgG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 930,
        "unit": "mg/dL",
        "reference_range": {
          "low": 700,
          "high": 1600
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2465-3",
            "display": "IgG [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic IgG before the 600 mg dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGM-V5",
        "display": "IgM [Mass/volume] in Serum or Plasma",
        "label": "IgM",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 46,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40,
          "high": 230
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2472-9",
            "display": "IgM [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic IgM before the 600 mg dose; low-normal, as is common on anti-CD20 therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V5",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 38,
        "unit": "ng/mL",
        "reference_range": {
          "low": 20,
          "high": 100,
          "text": "Below 20 ng/mL deficient; 20 to 29 insufficient"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D on maintenance cholecalciferol.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HBSAB-V5",
        "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
        "label": "Hepatitis B surface antibody",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-12",
        "value": 6,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 10,
          "text": "10 mIU/mL or more is protective"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "16935-9",
            "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic hepatitis B surface antibody after two vaccine doses, the second given after B-cell depletion; not protective (drawn late; see the deviation recorded at the fourth visit).",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-12",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-12",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGR-V5",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
        "label": "Nine-hole peg test, right hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-10-12",
        "value": 18.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83157-8",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test at six months. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEGL-V5",
        "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
        "label": "Nine-hole peg test, left hand",
        "status": "final",
        "category": "survey",
        "effective_date": "2026-10-12",
        "value": 19.5,
        "unit": "s",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "83156-0",
            "display": "9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nine-hole peg test at six months. Typical times for a woman of her age are about 17 to 19 seconds.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "MRI of the brain with and without gadolinium: 11 ovoid T2-hyperintense lesions, 3 mm to 9 mm, eight periventricular (several perpendicular to the ventricles), two juxtacortical and one in the right middle cerebellar peduncle; one periventricular lesion enhances; most lesions show a central vein; no mass, no meningeal enhancement",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16327691000119101",
            "display": "MRI of brain with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-12",
          "end": "2026-03-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic MRI three days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "MRI of the cervical and thoracic spine with and without gadolinium (same session): a short dorsal lesion at C3 to C4, less than one vertebral segment long and occupying under half the cord's cross-section, with patchy enhancement; a second, non-enhancing lesion at T7; no cord swelling or compression",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "702608007",
            "display": "MRI of cervical and thoracic spine with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-12",
          "end": "2026-03-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic spinal MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Lumbar puncture: clear fluid; white cells 6 per microliter (lymphocytes), protein 42 mg/dL, glucose normal; six oligoclonal bands in the cerebrospinal fluid not present in the serum; IgG index 0.86 (raised). Serum aquaporin-4 IgG by cell-based assay negative; HIV and syphilis serology negative",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "277762005",
            "display": "Lumbar puncture",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-16",
          "end": "2026-03-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic cerebrospinal fluid study a week after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "PROC-011",
        "display": "Advance care planning conversation, about 15 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-14",
          "end": "2026-09-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Occupational therapy assessment and program for hand function and fatigue: fine-motor and sensory re-education exercises for the fingers, graded return to practice in short blocks with rests, posture at the instrument, and energy management",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "84478008",
            "display": "Occupational therapy",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-03-30",
          "end": "2026-03-30"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic occupational therapy assessment a week after the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Re-baseline MRI of the brain with and without gadolinium three months after starting ocrelizumab: no new or enlarging T2 lesions and no enhancing lesions; the previously enhancing periventricular lesion is smaller",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16327691000119101",
            "display": "MRI of brain with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-08",
          "end": "2026-07-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic re-baseline MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2023-02-06",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Influenza vaccine, this season (inactivated)",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination for an adult on B-cell therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "COVID-19 mRNA vaccine, this season's formula",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine (PCV20), before B-cell therapy",
        "status": "completed",
        "date": "2026-03-23",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination three weeks before immunosuppressive therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, dose 1 of 2, before B-cell therapy",
        "status": "completed",
        "date": "2026-03-23",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster dose for an adult about to start immunosuppressive therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 1, before B-cell therapy",
        "status": "completed",
        "date": "2026-03-23",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for a non-immune adult before anti-CD20 therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (adjuvanted, two-dose series), dose 2",
        "status": "completed",
        "date": "2026-04-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second hepatitis B dose five weeks after the first, two weeks after B-cell depletion began.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-07-13",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second zoster dose about four months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-05T15:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Three weeks of numbness and clumsiness in the fingers of both hands, with Lhermitte's sign and fatigue, in a professional cellist of 28: examination, blood tests, and urgent MRI of the brain and spine",
        "status": "finished",
        "date": "2026-03-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Diagnosis of relapsing-remitting multiple sclerosis: neurology consultation, treatment of the relapse, choice of high-efficacy disease-modifying therapy, and vaccinations before B-cell therapy",
        "status": "finished",
        "date": "2026-03-23",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Diagnosis visit: MRI and lumbar puncture results and the neurology consultation",
          "hpi": {
            "narrative": "Ms. du Pré returns two weeks after her first visit. MRI of the brain and spine three days after that visit showed lesions typical of multiple sclerosis in the brain and the spinal cord, including an enhancing lesion at C3 to C4 that explains her hands, and the lumbar puncture a week ago showed oligoclonal bands in the spinal fluid only. Aquaporin-4 antibody was negative. She was seen today by Dr. Lindgren-Achebe. The numbness and clumsiness in her fingers are no better; she has practiced for only a few minutes at a time this week and has cancelled two more concerts. The electric feeling down her back when she bends her head continues. She is tired by mid-afternoon. She asked what multiple sclerosis will mean for her playing, and whether she can still have children.",
            "elements": [
              {
                "label": "Diagnosis",
                "value": "Relapsing-remitting multiple sclerosis, active: dissemination in space and time on MRI and CSF-specific oligoclonal bands"
              },
              {
                "label": "Tests since the first visit",
                "value": "MRI of the brain and cervical and thoracic spine with gadolinium; lumbar puncture; aquaporin-4 antibody; HIV and syphilis serology"
              },
              {
                "label": "Symptoms",
                "value": "Numb, clumsy fingers, worse on the left; Lhermitte's sign; fatigue"
              },
              {
                "label": "Her questions",
                "value": "Whether she will play again; whether she can have children; how treatment will fit around concerts and teaching"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired by mid-afternoon; no fever; weight steady"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Numbness and clumsiness of the fingers; Lhermitte's sign; no weakness of the legs, imbalance or visual change"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary urgency or burning; last period three weeks ago"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No blurred vision or pain on moving the eyes"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No back pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Frightened and tearful about her playing; PHQ-9 7, GAD-7 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 63.4 kg; blood pressure 114/72, pulse 76"
            },
            {
              "system": "Cranial nerves",
              "finding": "Normal; no nystagmus; visual acuity and fields normal"
            },
            {
              "system": "Neurological",
              "finding": "Reduced vibration and joint position sense in the fingers of both hands, worse on the left, with mild wandering of the left fingers when the eyes are closed; light touch reduced in the fingertips; finger and wrist strength 5 out of 5 except finger abduction 4+ on the left; brisk reflexes in the arms; Lhermitte's sign present; gait and balance normal. Nine-hole peg test 24.5 seconds right, 31.0 seconds left. EDSS 2.0"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm and expressive; anxious; asks exact questions"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis, active",
              "assessment": "Multiple sclerosis by the 2017 McDonald criteria: a current attack (partial cervical myelitis) with an earlier sensory episode in the history, dissemination in space (periventricular, juxtacortical, infratentorial and spinal cord lesions) and in time (enhancing and non-enhancing lesions together), with CSF-specific oligoclonal bands. The 2024 revision is also met, and most lesions show a central vein. Mimics were excluded: vitamin B12 and TSH were normal, aquaporin-4 antibody was negative, and HIV and syphilis serology were negative. MOG antibody was not tested, because nothing suggests MOG antibody disease (no optic neuritis, no long cord lesion, no ADEM-like picture). The relapse limits her hand function and her work, so high-dose steroids are offered. With active disease at 28, Dr. Lindgren-Achebe and she chose early high-efficacy therapy: ocrelizumab, over natalizumab because her JCV antibody is positive (index 1.4) with a higher risk of PML after two years, and over ofatumumab because she prefers two infusions a year to monthly injections when she travels",
              "plan": [
                "Methylprednisolone 1 g intravenously daily for 3 days from tomorrow; urine dipstick negative today",
                "Ocrelizumab 300 mg on day 1 in three weeks and on day 15, then 600 mg every six months",
                "PCV20, recombinant zoster dose 1 and hepatitis B dose 1 today, at least two weeks before the first infusion",
                "Occupational therapy for hand function and fatigue next week; MS specialist nurse contact"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Vitamin D deficiency",
              "assessment": "25-hydroxyvitamin D 16 ng/mL. Replaced to correct the deficiency; it is not a treatment for multiple sclerosis",
              "plan": [
                "Cholecalciferol 4000 units daily",
                "Level in about three months"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Numbness and clumsiness of the hands with Lhermitte's sign",
              "assessment": "Explained by the diagnosis made today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "MRI of the brain and cervical and thoracic spine with gadolinium",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Eleven typical brain lesions in periventricular, juxtacortical and infratentorial sites, one enhancing; enhancing C3 to C4 lesion and non-enhancing T7 lesion; central veins in most lesions",
              "guideline_ids": [
                "GL-MAGNIMS-2021",
                "GL-MCDONALD-2017",
                "GL-MCDONALD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Cerebrospinal fluid: oligoclonal bands, cell count, protein",
              "cadence": "At diagnosis when it adds certainty",
              "status": "up_to_date",
              "detail": "Six CSF-specific oligoclonal bands; IgG index 0.86; white cells 6, protein 42 mg/dL",
              "guideline_ids": [
                "GL-MCDONALD-2017",
                "GL-MCDONALD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Mimics: vitamin B12, TSH, HIV, syphilis",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "B12 468 pg/mL and TSH 1.6 mIU/L at the first visit; HIV and syphilis negative",
              "guideline_ids": [
                "GL-MCDONALD-2017",
                "GL-MCDONALD-2024",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Aquaporin-4 antibody (cell-based assay)",
              "cadence": "When a myelitis or optic neuritis raises neuromyelitis optica spectrum disorder",
              "status": "up_to_date",
              "detail": "Negative",
              "guideline_ids": [
                "GL-NMOSD-2015",
                "GL-MCDONALD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "MOG antibody",
              "cadence": "Only when the picture suggests MOG antibody disease",
              "status": "not_indicated",
              "detail": "No optic neuritis, long cord lesion or ADEM-like picture; typical MS lesions with central veins",
              "guideline_ids": [
                "GL-MCDONALD-2017",
                "GL-MCDONALD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "JCV antibody",
              "cadence": "Before choosing natalizumab, and every six months while on it",
              "status": "up_to_date",
              "detail": "Positive, index 1.4 (drawn with the lumbar puncture); natalizumab not chosen",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B (surface antigen, core antibody, surface antibody), varicella and measles immunity",
              "cadence": "Before anti-CD20 therapy",
              "status": "up_to_date",
              "detail": "Drawn with the lumbar puncture: hepatitis B surface antigen and core antibody negative, surface antibody negative (not immune); varicella IgG positive; measles immune by two recorded doses",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018",
                "GL-AAN-VACC-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Immunoglobulins (IgG, IgM)",
              "cadence": "At baseline and before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "IgG 1080 mg/dL, IgM 124 mg/dL",
              "observation_ids": [
                "OBS-IGG-V2",
                "OBS-IGM-V2"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "16 ng/mL: deficient",
              "observation_ids": [
                "OBS-VITD-V2"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test",
              "cadence": "Before steroids and before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "Urine pregnancy test negative",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Infection screen before high-dose steroids",
              "cadence": "Before each steroid course",
              "status": "completed_today",
              "detail": "Urine dipstick negative; no fever",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccinations before B-cell therapy",
              "cadence": "Inactivated vaccines at least two weeks before the first dose; live vaccines at least four weeks before",
              "status": "completed_today",
              "detail": "PCV20, recombinant zoster dose 1 and hepatitis B dose 1 given today; no live vaccine needed",
              "guideline_ids": [
                "GL-AAN-VACC-2019",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hand function: nine-hole peg test, both hands",
              "cadence": "At diagnosis, after a relapse, and at each review",
              "status": "completed_today",
              "detail": "24.5 seconds right, 31.0 seconds left (typical for her age about 17 to 19 seconds)",
              "observation_ids": [
                "OBS-PEGR-V2",
                "OBS-PEGL-V2"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological examination and EDSS",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "Sensory loss in the fingers, mild left finger weakness, Lhermitte's sign; EDSS 2.0",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "referral",
              "measure": "Occupational therapy",
              "cadence": "For any problem with hand function or fatigue",
              "status": "referred",
              "detail": "Assessment booked for next week",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood and anxiety (PHQ-9, GAD-7)",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "PHQ-9 7 (item 9 scored 0), GAD-7 6",
              "observation_ids": [
                "OBS-PHQ9-V2",
                "OBS-GAD7-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Pregnancy planning and contraception",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "Pregnancy is possible with multiple sclerosis; on ocrelizumab, conception is best planned a few months after a dose, with the neurologist; condoms for now",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Written information and MS specialist nurse",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Written information given; nurse contact and relapse line",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            }
          ],
          "follow_up": "Methylprednisolone from tomorrow for 3 days; occupational therapy next week; ocrelizumab day 1 in three weeks. Review at the second half-dose. Call at once for new weakness, imbalance, loss of vision or bladder control",
          "guideline_ids": [
            "GL-MCDONALD-2017",
            "GL-MCDONALD-2024",
            "GL-AAN-DMT-2018",
            "GL-ECTRIMS-2018",
            "GL-NICE-NG220",
            "GL-MAGNIMS-2021",
            "GL-AAN-VACC-2019"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Second half-dose of the first ocrelizumab course: recovery of hand function, infusion reactions, vaccination, practice and work",
        "status": "finished",
        "date": "2026-04-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Second half-dose of the first ocrelizumab course",
          "hpi": {
            "narrative": "Ms. du Pré comes on the day of her second 300 mg dose of ocrelizumab. The three days of intravenous methylprednisolone a month ago caused a few nights of poor sleep and a metallic taste, and within two weeks the feeling in her fingers began to come back. The first infusion two weeks ago caused an itchy throat and flushing an hour in, which settled when the rate was slowed. She has worked with the occupational therapist on finger exercises and practices in 20-minute blocks, about two hours a day, and has played through slow movements without losing her place. The electric feeling on bending her head is fainter. Her blood tests before the first infusion were normal. She is less tired.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Methylprednisolone 1 g for 3 days; ocrelizumab 300 mg two weeks ago; second 300 mg today"
              },
              {
                "label": "Infusion reaction",
                "value": "Mild throat itch and flushing with the first dose, settled by slowing the rate"
              },
              {
                "label": "Hand function",
                "value": "Feeling returning; practicing two hours a day in short blocks"
              },
              {
                "label": "Vaccination",
                "value": "Hepatitis B dose 2 today"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Less tired; no fever"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Tingling in the left fingertips, less than before; Lhermitte's sign fainter; no new symptoms"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Throat itch with the first infusion only"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Hopeful; PHQ-9 5; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 64.6 kg, up 1.2 kg after steroids; blood pressure 118/74"
            },
            {
              "system": "Neurological",
              "finding": "Vibration and joint position sense now only slightly reduced in the left fingers; no wandering of the fingers; strength normal; Lhermitte's sign faint. Nine-hole peg test 20.5 seconds right, 23.0 seconds left"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "finding": "Brighter and engaged"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis, on ocrelizumab",
              "assessment": "Good recovery from the relapse after steroids and occupational therapy: nine-hole peg times down from 24.5 and 31.0 to 20.5 and 23.0 seconds. The first infusion caused a mild infusion reaction, which is common with the first dose. Blood count and liver tests are normal and the glucose is normal after steroids. Urine pregnancy test negative today",
              "plan": [
                "Ocrelizumab 300 mg today, with premedication and the slower rate",
                "Hepatitis B vaccine dose 2 today",
                "Re-baseline MRI of the brain in about three months",
                "Continue occupational therapy; build practice up gradually"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Vitamin D deficiency",
              "assessment": "Taking cholecalciferol daily",
              "plan": [
                "Level in about two and a half months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count with lymphocytes",
              "cadence": "Before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "Hemoglobin 13.6 g/dL, white cells 7.9, lymphocytes 1.6, platelets 252",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-LYM-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests and glucose",
              "cadence": "After high-dose steroids and before each dose",
              "status": "completed_today",
              "detail": "ALT 21 U/L, AST 22 U/L; glucose 90 mg/dL",
              "observation_ids": [
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test",
              "cadence": "Before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "Urine pregnancy test negative",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, HIV and other screening before B-cell therapy",
              "cadence": "Before the first dose",
              "status": "up_to_date",
              "detail": "Reviewed at the diagnosis visit: no hepatitis B infection and not immune, so vaccination continues",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018",
                "GL-AAN-VACC-2019"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Infusion reactions",
              "cadence": "With each infusion",
              "status": "completed_today",
              "detail": "Mild reaction with dose 1 (throat itch, flushing); premedication and a slower rate today",
              "guideline_ids": [
                "GL-OPERA-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination",
              "cadence": "Complete series where possible",
              "status": "completed_today",
              "detail": "Hepatitis B dose 2 today; recombinant zoster dose 2 due in two to six months after dose 1",
              "guideline_ids": [
                "GL-AAN-VACC-2019",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hand function: nine-hole peg test, both hands",
              "cadence": "At diagnosis, after a relapse, and at each review",
              "status": "completed_today",
              "detail": "20.5 seconds right, 23.0 seconds left",
              "observation_ids": [
                "OBS-PEGR-V3",
                "OBS-PEGL-V3"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "referral",
              "measure": "Occupational therapy",
              "cadence": "Through recovery from the relapse",
              "status": "up_to_date",
              "detail": "Program started a week after the diagnosis visit",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Re-baseline MRI of the brain",
              "cadence": "Three to six months after starting a disease-modifying therapy",
              "status": "due",
              "detail": "Booked for about three months after the first dose",
              "guideline_ids": [
                "GL-MAGNIMS-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "About three months after starting replacement",
              "status": "due",
              "detail": "With the re-baseline MRI visit",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood and anxiety (PHQ-9, GAD-7)",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "PHQ-9 5; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fatigue: causes and management",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "Less tired; pacing practice in short blocks with rests",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            }
          ],
          "follow_up": "Re-baseline MRI and review in about ten weeks; occupational therapy continues; call for fever, urinary symptoms or any new neurological symptom",
          "guideline_ids": [
            "GL-AAN-DMT-2018",
            "GL-ECTRIMS-2018",
            "GL-OPERA-2017",
            "GL-AAN-VACC-2019",
            "GL-MAGNIMS-2021",
            "GL-NICE-NG220"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three months on ocrelizumab: re-baseline MRI, B-cell depletion, fatigue, vitamin D and hand function",
        "status": "finished",
        "date": "2026-07-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Three months on ocrelizumab: re-baseline MRI review",
          "hpi": {
            "narrative": "Ms. du Pré returns three months after her first ocrelizumab infusion, after a re-baseline MRI five days ago. The cystitis four weeks ago cleared with nitrofurantoin, and the tingling that came back with the fever went within two days of it. She has had no new symptoms. Feeling in her fingers is almost normal except after long practice, and she practices three hours a day. She has started swimming twice a week, which helps the fatigue, and rests after lunch. She played a private recital for friends last week. She takes cholecalciferol daily.",
            "elements": [
              {
                "label": "Disease activity",
                "value": "No relapse since starting ocrelizumab; re-baseline MRI with no new or enhancing lesions"
              },
              {
                "label": "Intercurrent illness",
                "value": "Cystitis with a pseudo-relapse four weeks ago, resolved"
              },
              {
                "label": "Hand function",
                "value": "Practicing three hours a day; private recital last week"
              },
              {
                "label": "Fatigue",
                "value": "Better with swimming, pacing and an after-lunch rest"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Mild late-afternoon fatigue; no fever"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Faint tingling in the left fingertips after long practice; no new symptoms"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms since the cystitis"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 4; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 64.0 kg; blood pressure 110/70"
            },
            {
              "system": "Neurological",
              "finding": "Vibration slightly reduced in the left fingertips only; joint position, strength, reflexes and gait normal; no Lhermitte's sign. Nine-hole peg test 19.0 seconds right, 20.5 seconds left. EDSS 1.0"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright, warm and engaged"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis, on ocrelizumab",
              "assessment": "No relapse and no new or enhancing lesions on the re-baseline MRI, which becomes the reference for future scans; the June episode was a pseudo-relapse with infection, not a relapse. Hand function nearly normal (nine-hole peg 19.0 and 20.5 seconds) and EDSS 1.0. B cells are depleted (CD19 3 per microliter), as expected, and IgG is normal. The hepatitis B surface antibody check due after her two vaccine doses was missed",
              "plan": [
                "Recombinant zoster vaccine dose 2 today",
                "Ocrelizumab 600 mg in three months, with blood count, immunoglobulins, hepatitis B surface antibody and a pregnancy test beforehand",
                "MRI of the brain yearly from now"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Vitamin D deficiency",
              "assessment": "25-hydroxyvitamin D 34 ng/mL after 16 weeks: corrected",
              "plan": [
                "Continue cholecalciferol 4000 units daily"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Acute cystitis with a pseudo-relapse",
              "assessment": "Resolved with nitrofurantoin; no recurrence",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Re-baseline MRI of the brain",
              "cadence": "Three to six months after starting a disease-modifying therapy, then yearly",
              "status": "up_to_date",
              "detail": "Five days ago: no new or enlarging T2 lesions, no enhancement",
              "guideline_ids": [
                "GL-MAGNIMS-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with lymphocytes",
              "cadence": "Every three to six months on ocrelizumab",
              "status": "completed_today",
              "detail": "Hemoglobin 13.5 g/dL, white cells 6.1, lymphocytes 1.5, platelets 240",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-LYM-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CD19 B-cell count",
              "cadence": "When needed to confirm depletion",
              "status": "completed_today",
              "detail": "3 per microliter: depleted, as expected",
              "observation_ids": [
                "OBS-CD19-V4"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Immunoglobulins (IgG, IgM)",
              "cadence": "At baseline and before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "IgG 990 mg/dL",
              "observation_ids": [
                "OBS-IGG-V4"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "About three months after starting replacement",
              "status": "completed_today",
              "detail": "34 ng/mL",
              "observation_ids": [
                "OBS-VITD-V4"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B surface antibody after vaccination",
              "cadence": "One to two months after the last dose, for people on immunosuppressive therapy",
              "status": "deferred",
              "detail": "Missed: the antibody check due one to two months after the second hepatitis B dose was not ordered. No harm is expected in the meantime, since she has no hepatitis B exposure; corrective action: added to the blood tests before the next ocrelizumab dose, and post-vaccination serology added to the clinic's B-cell therapy checklist",
              "guideline_ids": [
                "GL-AAN-VACC-2019",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination",
              "cadence": "Complete series where possible",
              "status": "completed_today",
              "detail": "Recombinant zoster dose 2 today",
              "guideline_ids": [
                "GL-AAN-VACC-2019",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Infections on anti-CD20 therapy",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "One uncomplicated cystitis, treated; no other infection",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hand function: nine-hole peg test, both hands",
              "cadence": "At diagnosis, after a relapse, and at each review",
              "status": "completed_today",
              "detail": "19.0 seconds right, 20.5 seconds left",
              "observation_ids": [
                "OBS-PEGR-V4",
                "OBS-PEGL-V4"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological examination and EDSS",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "EDSS 1.0",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood and anxiety (PHQ-9, GAD-7)",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "PHQ-9 4; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fatigue: causes and management",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "Aerobic exercise (swimming), pacing and rest; no medicine needed",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            }
          ],
          "follow_up": "Ocrelizumab 600 mg in three months with blood tests beforehand; preventive visit due; call for fever, urinary symptoms or any new neurological symptom",
          "guideline_ids": [
            "GL-AAN-DMT-2018",
            "GL-ECTRIMS-2018",
            "GL-MAGNIMS-2021",
            "GL-AAN-VACC-2019",
            "GL-NICE-NG220"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six months: first 600 mg dose of ocrelizumab, no evidence of disease activity, immunoglobulins, vaccination response, pregnancy planning and her return to performing",
        "status": "finished",
        "date": "2026-10-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Six months: first 600 mg dose of ocrelizumab",
          "hpi": {
            "narrative": "Ms. du Pré comes on the day of her first 600 mg dose of ocrelizumab, six months after starting treatment. She has had no relapse and no new symptoms. She played chamber music in public in August and last month, has a concerto booked for the spring, and gives master classes at a conservatory twice a month. Faint tingling in the left fingertips comes only after long practice. Fatigue is manageable with swimming and an after-lunch rest. She had influenza and COVID-19 vaccines a month ago. She asked when it would be safe to try for a baby, perhaps in a year or two.",
            "elements": [
              {
                "label": "Disease activity",
                "value": "No relapse in six months; re-baseline MRI clear"
              },
              {
                "label": "Treatment",
                "value": "Ocrelizumab 600 mg today"
              },
              {
                "label": "Music",
                "value": "Performing chamber music; concerto booked; teaching master classes"
              },
              {
                "label": "Her question",
                "value": "Pregnancy in a year or two"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy manageable; no fever"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Faint tingling in the left fingertips after long practice only"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Neck stiffness after practice, better with stretching"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Happy to be playing; PHQ-9 3, GAD-7 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 63.8 kg; blood pressure 112/70"
            },
            {
              "system": "Neurological",
              "finding": "Vibration slightly reduced in the left fingertips only; otherwise normal. Nine-hole peg test 18.5 seconds right, 19.5 seconds left. EDSS 1.0"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright and engaged"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis, on ocrelizumab",
              "assessment": "No evidence of disease activity at six months: no relapse, no new or enhancing lesions on the re-baseline MRI, and stable examination (EDSS 1.0, nine-hole peg 18.5 and 19.5 seconds). IgG 930 mg/dL is normal and IgM 46 mg/dL is low-normal, as is common on anti-CD20 therapy. Hepatitis B surface antibody is 6 mIU/mL after two doses, not protective, because the second dose came after B-cell depletion. Pregnancy: ocrelizumab does not need to be stopped long in advance; the usual plan is to try to conceive a few months after a dose, stopping contraception at that point, and to restart treatment after delivery; breastfeeding is possible",
              "plan": [
                "Ocrelizumab 600 mg today, then every six months",
                "Blood count and immunoglobulins before each dose; MRI of the brain yearly",
                "Hepatitis B: counsel on avoiding exposure; a booster is unlikely to work while B cells are depleted, so it is deferred and the antibody rechecked if treatment changes",
                "Preconception visit with the neurologist when she is ready"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Vitamin D deficiency",
              "assessment": "38 ng/mL on cholecalciferol",
              "plan": [
                "Continue cholecalciferol 4000 units daily"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count with lymphocytes",
              "cadence": "Before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "Hemoglobin 13.7 g/dL, white cells 6.0, lymphocytes 1.4, platelets 238",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-LYM-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Immunoglobulins (IgG, IgM)",
              "cadence": "At baseline and before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "IgG 930 mg/dL, IgM 46 mg/dL (low-normal)",
              "observation_ids": [
                "OBS-IGG-V5",
                "OBS-IGM-V5"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver tests",
              "cadence": "Before each dose",
              "status": "completed_today",
              "detail": "Creatinine 0.70 mg/dL, eGFR 121; ALT 18 U/L, AST 20 U/L",
              "observation_ids": [
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-ALT-V5",
                "OBS-AST-V5"
              ],
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "Every six to twelve months on replacement",
              "status": "completed_today",
              "detail": "38 ng/mL",
              "observation_ids": [
                "OBS-VITD-V5"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B surface antibody after vaccination",
              "cadence": "One to two months after the last dose",
              "status": "completed_today",
              "detail": "6 mIU/mL, not protective; drawn late (deviation recorded at the fourth visit)",
              "observation_ids": [
                "OBS-HBSAB-V5"
              ],
              "guideline_ids": [
                "GL-AAN-VACC-2019",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test",
              "cadence": "Before each ocrelizumab dose",
              "status": "completed_today",
              "detail": "Urine pregnancy test negative",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "MRI of the brain",
              "cadence": "Yearly on treatment",
              "status": "due",
              "detail": "Next about a year after the re-baseline scan",
              "guideline_ids": [
                "GL-MAGNIMS-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hand function: nine-hole peg test, both hands",
              "cadence": "At diagnosis, after a relapse, and at each review",
              "status": "completed_today",
              "detail": "18.5 seconds right, 19.5 seconds left",
              "observation_ids": [
                "OBS-PEGR-V5",
                "OBS-PEGL-V5"
              ],
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological examination and EDSS",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "EDSS 1.0; no change",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Infections on anti-CD20 therapy",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "None since June",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood and anxiety (PHQ-9, GAD-7)",
              "cadence": "At diagnosis and at each review",
              "status": "completed_today",
              "detail": "PHQ-9 3 (item 9 scored 0), GAD-7 3",
              "observation_ids": [
                "OBS-PHQ9-V5",
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Pregnancy planning",
              "cadence": "At each review in women who may become pregnant",
              "status": "completed_today",
              "detail": "Plan to conceive a few months after a dose, with a preconception visit",
              "guideline_ids": [
                "GL-AAN-DMT-2018",
                "GL-ECTRIMS-2018",
                "GL-NICE-NG220"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Fatigue: causes and management",
              "cadence": "Each review",
              "status": "completed_today",
              "detail": "Managed with exercise and pacing",
              "guideline_ids": [
                "GL-NICE-NG220"
              ]
            }
          ],
          "follow_up": "Ocrelizumab every six months; MRI of the brain in about nine months; primary care review in six months; preconception visit when she is ready",
          "guideline_ids": [
            "GL-AAN-DMT-2018",
            "GL-ECTRIMS-2018",
            "GL-MAGNIMS-2021",
            "GL-AAN-VACC-2019",
            "GL-NICE-NG220"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for cystitis with a pseudo-relapse",
        "status": "finished",
        "date": "2026-06-15",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Burning on passing urine and frequency for two days, with the tingling in her fingers back",
          "billing_note": "Problem-oriented office visit, established patient, with urine dipstick and culture",
          "hpi": {
            "narrative": "Ms. du Pré called the clinic on the second day of burning on passing urine, frequency and urgency, and was seen the same day. Since yesterday she has felt feverish (37.8 °C at home) and the tingling in the fingers of her left hand, which had almost gone, has come back, with the fingers feeling a little clumsy on the fingerboard this morning. There is no new weakness, no unsteadiness, no change in vision and no back or loin pain. She has had no vaginal discharge and her last period was two weeks ago. She completed the first ocrelizumab course seven weeks ago. She is afraid this is a new relapse and asked whether she needs steroids again. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Onset",
                "value": "Two days ago"
              },
              {
                "label": "Severity",
                "value": "Burning, frequency and urgency; low fever; no loin pain"
              },
              {
                "label": "Context",
                "value": "Seven weeks after the first ocrelizumab course; infections are more common on anti-CD20 therapy"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Old tingling in the left fingers returned with the fever; no new deficit"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Feverish and tired since yesterday"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Burning, frequency and urgency; no blood in the urine, no discharge, no loin pain"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Returning tingling in the left fingers since the fever; no new weakness, imbalance or visual change"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No vomiting, diarrhea or abdominal pain"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No back pain"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Worried about a relapse; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, a little flushed; temperature 37.8 °C; pulse 92"
            },
            {
              "system": "Abdomen",
              "finding": "Mild suprapubic tenderness; no loin tenderness"
            },
            {
              "system": "Neurological",
              "finding": "Unchanged from the last visit: light touch and vibration slightly reduced in the left fingertips, joint position normal, strength and reflexes as before, gait normal; no new sign"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Acute uncomplicated cystitis with a pseudo-relapse",
              "assessment": "Acute cystitis: the dipstick shows leukocyte esterase and nitrites, and the culture later grew Escherichia coli sensitive to nitrofurantoin; white cells 10.2 and CRP 14 mg/L. There is no loin pain and the fever is low, so this is not pyelonephritis. The return of old tingling with a fever and no new sign is a pseudo-relapse, caused by the infection and the raised temperature acting on an old lesion, not new inflammation, so steroids are not needed",
              "plan": [
                "Nitrofurantoin 100 mg twice daily for 5 days",
                "Plenty of fluids; acetaminophen for fever",
                "If the tingling has not settled within a day or two of the fever going, or any new symptom appears, call: that would need a neurological review and MRI",
                "Call at once for loin pain, rigors or vomiting"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis on ocrelizumab",
              "assessment": "First course completed seven weeks ago; hand function had nearly recovered before this illness",
              "plan": [
                "Re-baseline MRI and review in four weeks, as booked"
              ]
            }
          ],
          "follow_up": "Phone call in two days. Review with the re-baseline MRI in four weeks. Call for loin pain, high fever or any new neurological symptom",
          "guideline_ids": [
            "GL-IDSA-UTI-2011",
            "GL-NICE-NG220"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is a synthetic intercurrent infection, not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit on B-cell therapy",
        "status": "finished",
        "date": "2026-09-14",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Thackeray-Osei",
          "hpi": {
            "narrative": "Ms. du Pré, 28, comes for her yearly preventive visit five months after starting ocrelizumab. She has had no relapse; the cystitis in June cleared with nitrofurantoin and the tingling that came with it went within two days. She practices three to four hours a day, played chamber music in public last month for the first time this year, and teaches two students a week. Fatigue comes in the late afternoon and she plans her day around it. She takes cholecalciferol 4000 units daily. Her PHQ-9 today is 3.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 28"
              },
              {
                "label": "Active conditions",
                "value": "Relapsing-remitting multiple sclerosis on ocrelizumab; vitamin D deficiency on replacement"
              },
              {
                "label": "Medicines",
                "value": "Ocrelizumab every six months (next dose next month); cholecalciferol 4000 units daily"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 3"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and much better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with practice, teaching and concerts; worries about another relapse; good support from friends"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "A glass of wine two or three evenings a week; no drugs"
            },
            {
              "domain": "Physical activity",
              "finding": "Swims twice a week and walks daily, as the occupational therapist suggested for fatigue"
            },
            {
              "domain": "Nutrition",
              "finding": "Regular meals; no restrictions"
            },
            {
              "domain": "Sleep",
              "finding": "Eight hours; rests for half an hour after lunch"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "Condoms used consistently; not planning a pregnancy this year"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; no one hurts, threatens or controls her"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; does not drive when tired"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Late-afternoon fatigue, managed with pacing; no fever or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No blurred vision or pain on moving the eyes"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing change"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels regular"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urgency or burning since June"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Some neck and shoulder stiffness after long practice"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or changing moles"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Faint tingling in the left fingertips after long practice; no weakness or imbalance"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 63.9 kg, BMI 21.4; blood pressure 110/70"
            },
            {
              "system": "Head, eyes, ears, nose, and throat",
              "finding": "Normal; fundi normal"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes; thyroid normal"
            },
            {
              "system": "Breasts",
              "finding": "Examined with her agreement and a chaperone: no mass or nipple discharge; no axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender"
            },
            {
              "system": "Skin",
              "finding": "No rash; no suspicious moles"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Tight upper trapezius muscles; full neck movement"
            },
            {
              "system": "Neurological",
              "finding": "Vibration slightly reduced in the left fingertips only; strength, reflexes and gait normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright, warm and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated for a woman of 28 on B-cell therapy for multiple sclerosis. Inactivated influenza and COVID-19 vaccines given today; responses may be reduced while B cells are depleted, but the vaccines still protect and are recommended. Live vaccines are avoided on ocrelizumab; she is immune to measles and varicella. Pneumococcal and recombinant zoster vaccines were completed before and during treatment. The hepatitis B surface antibody check after her two hepatitis B doses has not yet been drawn and will be done with next month's blood tests. Cervical screening is up to date. Contraception was discussed again: she uses condoms consistently and was offered an IUD or implant for more reliable protection during treatment; she will consider it",
              "plan": [
                "Influenza and COVID-19 vaccines given today",
                "Hepatitis B surface antibody with the blood tests before the next ocrelizumab dose",
                "Cervical screening next year",
                "Stretching and posture work for neck and shoulder strain from practice",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Relapsing-remitting multiple sclerosis on ocrelizumab",
              "assessment": "No relapse since starting treatment; the re-baseline MRI two months ago showed no new or enhancing lesions",
              "plan": [
                "Ocrelizumab 600 mg next month, with blood count, immunoglobulins and a pregnancy test beforehand"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "110/70 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 3; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "Two or three glasses of wine a week; low risk",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "up_to_date",
              "detail": "Cytology two years ago normal; next at three years",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Chlamydia and gonorrhea screening",
              "status": "not_indicated",
              "detail": "Over 24 and not at increased risk",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV, hepatitis B and hepatitis C screening",
              "status": "up_to_date",
              "detail": "All negative before treatment",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "Inactivated vaccine, about five weeks before the next ocrelizumab dose",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-AAN-VACC-2019"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "completed_today",
              "detail": "This season's mRNA vaccine",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-AAN-VACC-2019"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 before treatment, for an adult starting immunosuppressive therapy",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "up_to_date",
              "detail": "Two doses, before and during treatment",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "due",
              "detail": "Two doses given; the surface antibody check after the series is due with next month's blood tests",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "up_to_date",
              "detail": "Series completed in adolescence",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap three years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Live vaccines (MMR, varicella)",
              "status": "not_indicated",
              "detail": "Immune to measles and varicella; live vaccines are avoided on ocrelizumab",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-AAN-VACC-2019"
              ]
            },
            {
              "service": "Contraception counseling",
              "status": "completed_today",
              "detail": "Condoms used consistently; IUD or implant offered for more reliable protection during treatment",
              "guideline_ids": [
                "GL-ECTRIMS-2018"
              ]
            },
            {
              "service": "Dental and vision examination",
              "status": "due",
              "detail": "Dental check due; eye examination normal today on fundoscopy, optometry yearly",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 15 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here. She said that she wants to be told plainly about her illness and its treatment, that she wants every treatment that can keep her playing and independent, and that if she were ever too ill to decide she would want her wishes about music and comfort respected. To be revisited at each change in her health and at least yearly.",
          "follow_up": "Ocrelizumab 600 mg next month with blood tests and hepatitis B surface antibody beforehand. Cervical screening next year. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-AAN-VACC-2019",
            "GL-USPSTF-CERV-2018"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at presentation; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-23",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 114,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-07-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-06-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: low-grade fever.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 173,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:30:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Professional cellist: solo and chamber concerts and recordings, and teaching; practices three to five hours a day; has cancelled most concerts this season because her fingers will not do what she asks",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career and the end of her performing.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Married, with no children; lives in London with her husband, a pianist and conductor, who travels often for work; close friends among musicians. No relative is named or given a role in her care",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic household anchored to her documented marriage; no real person is given a role or a health fact.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Never smoker; alcohol a glass of wine with dinner some evenings; no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Periods regular; uses condoms for contraception; not planning a pregnancy this year but would like to discuss it in future",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Warm, funny and expressive; frightened that something is wrong with her hands and tired of being told it is stress",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic preference anchored to her documented years of unexplained symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in daily activities; fine finger work slowed (buttons, writing, fingering); walking normal; tired by mid-afternoon",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, warm and articulate; anxious about her hands; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Suspected demyelinating disease in a 28-year-old professional cellist with three weeks of numbness, loss of position sense and clumsiness in the fingers of both hands, worse on the left, Lhermitte's sign and fatigue, after a similar month of finger tingling 18 months ago. MRI of the brain and cervical and thoracic spine with gadolinium is booked this week. Please see her within two weeks to review the MRI with her, confirm or exclude multiple sclerosis, and plan treatment",
        "urgency": "Urgent, within two weeks",
        "pertinent_history": "Three weeks of numbness and tingling in the fingers of both hands, worse on the left (her fingering hand); she cannot feel the strings properly, loses her place on the fingerboard and has dropped her bow; an electric sensation down the spine on bending the neck; tired by mid-afternoon for months. Eighteen months ago a month of finger tingling was put down to overwork and settled. No visual, bladder or gait symptoms. Weight 63.5 kg; blood pressure 112/70. Reduced vibration and position sense in the fingers, worse on the left; nine-hole peg test 26.0 seconds right and 33.5 seconds left. Results today: hemoglobin 13.4 g/dL, lymphocytes 1.9, platelets 246; creatinine 0.72 mg/dL; glucose 86 mg/dL; ALT 16 and AST 19 U/L; vitamin B12 468 pg/mL; TSH 1.6 mIU/L. No medicines; no known allergies. Never smoker. Married; uses condoms; not planning a pregnancy this year. She is a professional cellist who has cancelled most concerts this season and wants to know whether she will play again",
        "questions": [
          "Does she have multiple sclerosis by current criteria, and what further tests are needed, including tests for mimics?",
          "Should the current episode be treated, and how?",
          "Which disease-modifying therapy do you recommend, and why, given her age, activity, travel and wish for children in future?",
          "What screening and vaccinations are needed before treatment, and what monitoring should primary care share?",
          "What can be done for her hand function and fatigue so that she can keep playing and teaching?"
        ]
      },
      "consultant_note": {
        "history": "Ms. du Pré, 28, is seen at the request of Dr. Thackeray-Osei two weeks after she presented with numbness and clumsiness of the fingers of both hands, Lhermitte's sign and fatigue. She has since had MRI of the brain and spine with gadolinium and a lumbar puncture. Her fingers are no better: she can practice only a few minutes at a time and has cancelled two more concerts. She recalls a month of finger tingling about 18 months ago that settled without treatment; she has had no visual loss, double vision, imbalance or bladder symptoms. She travels for concerts and teaches. She is not planning a pregnancy this year but would like children in future",
        "data_reviewed": "Dr. Thackeray-Osei's intake note and results. MRI of the brain with gadolinium: eleven ovoid T2 lesions, eight periventricular (several perpendicular to the ventricles), two juxtacortical and one in the right middle cerebellar peduncle; one periventricular lesion enhances; central veins in most lesions. MRI of the cervical and thoracic spine: short dorsal lesion at C3 to C4 with patchy enhancement, non-enhancing lesion at T7, no swelling. Lumbar puncture: white cells 6, protein 42 mg/dL, six CSF-specific oligoclonal bands, IgG index 0.86. Serum aquaporin-4 IgG (cell-based) negative; HIV and syphilis negative; JCV antibody positive, index 1.4. Vitamin B12 468 pg/mL and TSH 1.6 mIU/L at the first visit. Drawn with the lumbar puncture: hepatitis B surface antigen and core antibody negative, surface antibody negative; varicella IgG positive. Today: 25-hydroxyvitamin D 16 ng/mL; IgG 1080 and IgM 124 mg/dL; urine pregnancy test negative",
        "exam": [
          {
            "system": "Cranial nerves",
            "finding": "Normal; no nystagmus; normal acuity, fields and fundi"
          },
          {
            "system": "Motor",
            "finding": "Strength 5 out of 5 except left finger abduction 4+; tone normal; reflexes brisk in the arms, normal in the legs; plantar responses flexor"
          },
          {
            "system": "Sensory",
            "finding": "Reduced vibration and joint position sense in the fingers of both hands, worse on the left, with mild pseudoathetosis of the left fingers with the eyes closed; Lhermitte's sign present"
          },
          {
            "system": "Coordination and gait",
            "finding": "Nine-hole peg test 24.5 seconds right, 31.0 seconds left; finger-nose normal; gait, tandem and Romberg normal. EDSS 2.0"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Relapsing-remitting multiple sclerosis, active",
            "assessment": "Multiple sclerosis by the 2017 McDonald criteria: a current attack of partial cervical myelitis, with dissemination in space in four regions and dissemination in time shown by enhancing and non-enhancing lesions on the same scan; CSF-specific oligoclonal bands add certainty. The 2024 revision is also met, and central veins support the diagnosis. The earlier episode of finger tingling was probably a first attack. Mimics were considered and excluded: normal B12 and thyroid function, negative aquaporin-4 antibody (a cell-based assay is needed for any myelitis), negative HIV and syphilis serology. MOG antibody testing is not indicated: there is no optic neuritis, long cord lesion or ADEM-like illness, and the lesions are typical of MS. With a disabling relapse, an enhancing cord lesion and multiple lesions at 28, her disease is active, and early high-efficacy treatment gives the best long-term outcome"
          },
          {
            "problem_id": "PRB-003",
            "display": "Vitamin D deficiency",
            "assessment": "Correct the deficiency; vitamin D is not a treatment for MS"
          }
        ],
        "recommendations": [
          "Treat the relapse, which limits her hand function and her work: methylprednisolone 1 g intravenously daily for 3 days after a negative urine dipstick (oral methylprednisolone 500 mg daily for 5 days is an equivalent alternative)",
          "Early high-efficacy disease-modifying therapy with ocrelizumab: 300 mg intravenously on day 1 and day 15, then 600 mg every six months, with methylprednisolone 100 mg, an antihistamine and acetaminophen before each infusion. Natalizumab is not advised because her JCV antibody is positive, which raises the risk of PML with longer use; ofatumumab is an equally effective option that she declined in favor of twice-yearly infusions",
          "Before the first infusion: hepatitis B screening (done; not immune), immunoglobulins, varicella and measles immunity, and a pregnancy test; inactivated vaccines at least two weeks before (PCV20, recombinant zoster and hepatitis B started today), and no live vaccines once treatment starts. Check hepatitis B surface antibody one to two months after the series",
          "Re-baseline MRI of the brain three to six months after starting, then yearly; blood count and immunoglobulins before each dose; teach her that infections, especially urinary infections, are more common and can cause a pseudo-relapse that does not need steroids",
          "Occupational therapy for hand function and energy management, and a graded return to practice; aerobic exercise and pacing for fatigue after excluding other causes",
          "Cholecalciferol 4000 units daily for the deficiency, with a level in three months",
          "Pregnancy: contraception for now; when she is ready, a preconception visit, with conception planned a few months after an ocrelizumab dose",
          "Primary care to share the monitoring: blood tests before infusions, vaccinations, infection review, mood and fatigue"
        ],
        "communication": "Discussed with Dr. Thackeray-Osei the same day. The MRI and spinal fluid results were shown and explained to Ms. du Pré in plain words, with the good outlook for hand recovery after a first cord relapse and the evidence that early high-efficacy treatment protects long-term function. She chose ocrelizumab. She decides who else receives this note",
        "follow_up": "Methylprednisolone from tomorrow; first ocrelizumab infusion in three weeks; neurology review at three months with the re-baseline MRI, then every six months; MS specialist nurse available between visits"
      },
      "guideline_ids": [
        "GL-MCDONALD-2017",
        "GL-MCDONALD-2024",
        "GL-AAN-DMT-2018",
        "GL-ECTRIMS-2018",
        "GL-NICE-NG220",
        "GL-MAGNIMS-2021",
        "GL-NMOSD-2015",
        "GL-OPERA-2017",
        "GL-AAN-VACC-2019"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "For three weeks the fingers of both hands have been numb and tingling, worse on the left; she cannot feel the strings properly, loses her place on the fingerboard and has dropped her bow twice; an electric feeling runs down her back when she bends her head; tired by mid-afternoon for months",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic presenting concern anchored to her documented loss of sensation in her fingers and fatigue.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "A similar month of tingling in her fingers 18 months ago was put down to overwork and stress, and settled",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic history illustrating the delay in diagnosing multiple sclerosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants to know what is wrong, and whether she will be able to play again",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "MRI of the brain and spine within one week and a neurology diagnosis within three weeks",
        "status": "completed",
        "target_date": "2026-03-23",
        "outcome": "MRI in three days, lumbar puncture in a week, diagnosis and consultation at two weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "High-efficacy disease-modifying therapy started within six weeks of diagnosis, after screening and vaccinations",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "Ocrelizumab started three weeks after the diagnosis; PCV20, recombinant zoster and hepatitis B vaccines given first",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Nine-hole peg times back to within 10 percent of normal in both hands, and full practice resumed",
        "status": "completed",
        "target_date": "2026-07-13",
        "outcome": "19.0 seconds right and 20.5 seconds left at three months; practicing three hours a day",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hand-function goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "No evidence of disease activity at six months (no relapse, no new or enhancing MRI lesion, no disability progression)",
        "status": "completed",
        "target_date": "2026-10-12",
        "outcome": "No relapse; re-baseline MRI with no new or enhancing lesions; examination stable",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic disease-control goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "25-hydroxyvitamin D of 30 ng/mL or more",
        "status": "completed",
        "target_date": "2026-07-13",
        "outcome": "34 ng/mL after 16 weeks of cholecalciferol",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "PHQ-9 below 10 throughout",
        "status": "completed",
        "target_date": "2026-10-12",
        "outcome": "PHQ-9 between 3 and 7",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Neurology (multiple sclerosis) consultation within two weeks to review the MRI with her and make a diagnosis and plan",
        "status": "completed",
        "guideline_ids": [
          "GL-AAN-DMT-2018",
          "GL-NICE-NG220"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake so that an abnormal MRI reaches a neurologist without delay.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Urgent work-up of a sensory syndrome of both hands with Lhermitte's sign: MRI of the brain and cervical and thoracic spine with gadolinium within a week; blood count, chemistry, vitamin B12 and TSH; lumbar puncture for oligoclonal bands if the MRI is suggestive; return at once for weakness, unsteadiness, loss of bladder control or loss of vision",
        "status": "completed",
        "guideline_ids": [
          "GL-MCDONALD-2017",
          "GL-MAGNIMS-2021",
          "GL-NICE-NG220"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic diagnostic pathway; it guards against the delay she had in the past.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Relapse treatment: methylprednisolone 1 g intravenously daily for three days for a relapse that limits her hand function, after excluding infection; occupational therapy for hand function and energy management",
        "status": "completed",
        "guideline_ids": [
          "GL-NICE-NG220",
          "GL-ECTRIMS-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic relapse plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-004",
        "display": "Early high-efficacy disease-modifying therapy with ocrelizumab: 300 mg intravenously on days 1 and 15, then 600 mg every six months, with premedication; chosen over natalizumab because the JCV antibody is positive and over ofatumumab at her preference for twice-yearly infusions; before the first dose, hepatitis B screening, varicella and measles immunity, immunoglobulins, a pregnancy test, and inactivated vaccines at least two weeks ahead; contraception during treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-AAN-DMT-2018",
          "GL-ECTRIMS-2018",
          "GL-OPERA-2017",
          "GL-AAN-VACC-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic treatment chosen at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-005",
        "display": "Vitamin D: cholecalciferol 4000 units daily to correct deficiency, with a level after three months; not as a treatment for multiple sclerosis",
        "status": "completed",
        "guideline_ids": [
          "GL-NICE-NG220"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic vitamin D plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-006",
        "display": "Monitoring on ocrelizumab: re-baseline MRI of the brain three to six months after starting, then yearly; blood count and immunoglobulins before each dose; infection and pseudo-relapse teaching; pregnancy planning, with conception timed after a dose",
        "status": "completed",
        "guideline_ids": [
          "GL-MAGNIMS-2021",
          "GL-ECTRIMS-2018",
          "GL-AAN-DMT-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0012"
          ],
          "synthetic_reason": "Synthetic monitoring plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-03-23"
      },
      {
        "id": "INT-007",
        "display": "Fatigue, mood and work: screening for depression and sleep problems at each visit, plain explanations with written information, and a plan built around her practice, performing and teaching; she decides who is told and who receives each note",
        "status": "completed",
        "guideline_ids": [
          "GL-NICE-NG220",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-AAN-DMT-2018",
        "title": "Rae-Grant A, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology 2018;90(17):777-788 (PMID 29686116)",
        "publisher": "American Academy of Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29686116/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-ECTRIMS-2018",
        "title": "Montalban X, et al. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018;24(2):96-120 (PMID 29353550)",
        "publisher": "European Committee for Treatment and Research in Multiple Sclerosis / European Academy of Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29353550/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-NICE-NG220",
        "title": "Multiple sclerosis in adults: management (NICE guideline NG220)",
        "publisher": "National Institute for Health and Care Excellence",
        "url": "https://www.nice.org.uk/guidance/ng220",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-MCDONALD-2017",
        "title": "Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-173 (PMID 29275977)",
        "publisher": "The Lancet Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29275977/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-MCDONALD-2024",
        "title": "Montalban X, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 2025;24(10):850-865 (doi:10.1016/S1474-4422(25)00270-4)",
        "publisher": "The Lancet Neurology",
        "url": "https://doi.org/10.1016/S1474-4422(25)00270-4",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-MAGNIMS-2021",
        "title": "Wattjes MP, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 2021;20(8):653-670 (PMID 34139157)",
        "publisher": "The Lancet Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34139157/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-NMOSD-2015",
        "title": "Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177-189 (PMID 26092914)",
        "publisher": "Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/26092914/",
        "version_or_year": "2015"
      },
      {
        "guideline_id": "GL-OPERA-2017",
        "title": "Hauser SL, et al. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med 2017;376(3):221-234 (PMID 28002679)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/28002679/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-AAN-VACC-2019",
        "title": "Farez MF, et al. Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis. Neurology 2019;93(13):584-594 (PMID 31462584)",
        "publisher": "American Academy of Neurology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31462584/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-IDSA-UTI-2011",
        "title": "Gupta K, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the IDSA and ESCMID. Clin Infect Dis 2011;52(5):e103-e120 (PMID 21292654)",
        "publisher": "Infectious Diseases Society of America",
        "url": "https://pubmed.ncbi.nlm.nih.gov/21292654/",
        "version_or_year": "2011"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the application of the 2017 McDonald criteria and the 2024 revision, the decision to test aquaporin-4 but not MOG antibody, intravenous rather than oral methylprednisolone for the relapse, the choice of ocrelizumab over natalizumab (JCV antibody positive) and ofatumumab, the timing of vaccines before B-cell depletion, and the management of a pseudo-relapse with cystitis."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "She died in 1987; the recent-death rule does not apply, but her husband and siblings are living or recently living public people and none of them is named; contested family accounts are not used. Claims rest on a 2018 peer-reviewed review, an essay by two Mayo Clinic physicians, Wikipedia and Women in World History; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail, and later disputed claims about it are not used. No relative is named or given a role in the modern episode."
    }
  }
}
